ARCHIVES

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

New Tool Found To Cut DNA At Any Position

April 4, 1986

Entire Construction Budget In 1983 Goes to Two Grants; Help May Be On The Way

February 25, 1983

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011

GSK HPV Vaccine Offers Protection From 4 HPV Types

April 27, 2007

In Brief: Grace Powers Monaco Receives Lloyd Bentsen Award

July 21, 1995

CCOPs, Research Base Awards Are Listed

November 19, 1993